Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis-Reference-Cited by-同舟云学术

Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis

Published:2021-12 Issue:12 Volume:9 Page:825-836
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference36 articles.

1. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives;Chan;Lancet,2021

2. Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials;Palmer;BMJ,2021

3. Comparative effectiveness of glucose-lowering drugs for type 2 diabetes: a systematic review and network meta-analysis;Tsapas;Ann Intern Med,2020

4. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2021;Diabetes Care,2021

5. 2019 update to: management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Buse;Diabetologia,2020

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of glucagon-like peptide-1 receptor agonists (GLP1-RAs) in the management of the hypertensive patient with metabolic syndrome: a position paper from the Korean society of hypertension;Clinical Hypertension;2024-09-01

2. A conceptual framework to build effective medicine pricing policies for low and middle-income countries (LMICs);Research in Social and Administrative Pharmacy;2024-09

3. Burden of Disease in Refugee Patients with Diabetes on the Island of Lesvos—The Experience of a Frontline General Hospital;International Journal of Environmental Research and Public Health;2024-06-25

4. Effect of a multicomponent quality improvement strategy on sustained achievement of diabetes care goals and macrovascular and microvascular complications in South Asia at 6.5 years follow-up: Post hoc analyses of the CARRS randomized clinical trial;PLOS Medicine;2024-06-03

5. Applications of SGLT2 inhibitors beyond glycaemic control;Nature Reviews Nephrology;2024-04-26